Pharmaceutical compositions for prevention and treatment of ulcerative colitis
Patent 5604231 Issued on February 18, 1997. Estimated Expiration Date: January 6, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
514/256, 1,3-diazines (e.g., pyrimidines, etc.)514/277, Hetero ring is six-membered consisting of one nitrogen and five carbon atoms514/357Nitrogen attached indirectly to the six-membered hetero ring by nonionic bonding
Patients suffering from or susceptible to an idiopathic chronic inflammatory bowel disease (e.g., ulcerative colitis) are treated with pharmaceutical compositions. Those patients are treated by administration of an effective amount of aryl substituted aliphatic compound, an aryl substituted olefinic amine compound or an aryl substituted acetylenic compound. Exemplary compounds are (E)-4-(5-pyrimidinyl)-3-butene-1-amine, (E)-4-[3-(5-methoxypyridin)yl]-3-butene-1-amine, (E)-N-methyl-4-(5-pyrimidinyl)-3-butene-1-amine, (E)-N-methyl-4-[3-(5-methoxypyridin)yl]-3-butene-1-amine, (E)-metanicotine, (Z)-metanicotine, N-methyl-(3-pyridinyl)-butane-1-amine, N-methyl-4-(3-pyridinyl)-3-butyne-1-amine and (E)-N-methyl-4 -[3-(6-methylpyrindin)yl]-3-butone-1-amine.
Other References
Cecil Testbook of Medicine, 19th Edition, pp. 699-708, Ed. by Wyngaarden et al. Dec. 1992
Amaral-Corfield, C. et al., "The glycoconjugate content of rectal biopsies from normal and ulcerative colitic non-smokers", Med. Sci. Res., vol. 19, pp. 309-310 Dec. 1991
Barton, J. et al., "Mucosalimmunodeficiency in smokers, and in patients with epithelial head and neck tumors", Gut, vol. 31. 378-382 Dec. 1990
Boyko, E. et al., "Effects of Cigarette Smoking on the Clinical Course of Ulcerative Colitis", Scandinavian Journal of Gastroenterology, vol. 23 (9), pp. 1147-1152 Dec. 1988
Calkins, B., "A Meta-Analysis of the Role of Smoking in Inflammatory Bowerl Disease", Digestive Diseases and Sciences, vol. 34 (12), pp. 1841-1854 Dec. 1989
Castella, H., "Non-smoking: a feature of ulcerative colitis", BMJ, vol. 284, p. 1706 Dec. 1982
Cope, G. et al., "Cigarette smoking and intestinal defences", Gut, vol. 33, 721-723 Dec. 1992
Guslandi, M. et al., "Steroid-Sparing Effect of Transdermal Nicotine in Ulcerative Colitis", J. Clin. Gastroenterol., vol. 18 (4), pp. 347-350 Jun. 1994
Jameson, J. et al., "The Effect of Smoking on Colonic Pressure Activity", Gastroentenology, vol. 104 (4) (Suppl.), p. A527 Dec. 1993
Jick, H. et al., "Cigarette Smoking and Ulcerative Colitis", New England Journal of Medicine, vol. 308, pp. 261-263 Dec. 1983
Katchinski, B., "Smoking and Sugar Intake in Ulcerative Colitis", AGA Abstracts, vol. 98 (5) (part 2), p. A180 Dec. 1990
Kirsner, J. et al., "Recent Developments in Nonspecific Inflammatory Bowel Disease", New England Journal of Medicine, vol. 306 (13), pp. 775-784 Dec. 1982
Lashner, B., "Conspectus Inflammatory Bowel Disease, Family Patterns and Risk Factors", Comprehensive Therapy, vol. 18 (8), pp. 2-4 Dec. 1992
Lashner, B. et al., "Testing Nicotine Gum for Ulcerative Colitis Patients", Digestive Diseases and Sciences, vol. 35 (7), pp. 827-832 Dec. 1990
Macpherson, A. et al, "Inflammatory bowel disease of mice-and men?", The Lancet, vol. 343, pp. 130-131 Jan. 1994
Motley, R. et al., "Smoking, eicosanoids and ulcerative colitis", J. Pharm. Pharmacol., vol. 42, pp. 288-289 Dec. 1990
Perera D. et al., "Smoking and ulcerative colitis", British Medical Journal, vol. 288, p. 1533 Dec. 1984
Pullan, R. et al., "Transdermal Nicotine for Active Ulcerative Colitis", New England Journal of Medicine, vol. 330 (12), pp. 811-815 Mar. 1994
Prytz, H. et al., "Does Smoking Tighten the Gut?", Scand. J. Gastroenterol., vol. 24, pp. 1084-1088 Dec. 1989
Rhodes, J. et al., "Smoking: Good or Bad for Inflammatory Bowel Disease?", Gastroenterology, vol. 106 (3), pp. 807-810 Mar. 1994
Roberts, C. et al., "Non-smoking: a feature of ulcerative colitis", BMJ, vol. 285, p. 440 Dec. 1982
Rudra, T. et al., "Does Smoking Improve Colitis?", Scand. J. Gastroenterol., vol. 24 (suppl. 170), pp. 61-63 Dec. 1989
Samuelsson, S. et al., "Risk factors for extensive ulcerative colitis and ulcerative proctitis: a population based case-control study", Gut, vol. 32, pp. 1526-1530 Dec. 1991
Shivananda, S. et al., "Epidemiology of inflammatory bowel disease", Current Opinion in Gastroenterology, vol. 9, pp. 560-565 Dec. 1993
Srivastava, E. et al., "Effect of ulcerative colitis and smoking on rectal blood flow", Gut, vol. 31, pp. 1021-1024 Dec. 1990
Srivastava, E. et al., "Smoking, humoral immunity, and ulcerative colitis", Gut, vol. 32, pp. 1016-1019 Dec. 1991
Srivastava, E. et al., "Transdermal nicotine in active ulcerative colitis", European Journal of Gastroenterology & Hepatology, vol. 3, pp. 815-818 Dec. 1991
Srivastava, E. et al., "Effect of Nicotine and Cotinine on the Production of Oxygen Free Radicals by Neutrophils in Smokers and Non-smokers", Human Toxicol., vol. 8, pp. 461-463 (Dec. 1989)
Thomas and Rhodes, International Symposium on Nicotine, S38, Jul. 1994, eds. Clarke et al
Zijlstra, F. et al., "Effect of nicotine on rectal mucus and mucosal eicosanoids", Gut, vol. 35, pp. 247-251 Feb. 1994
Physicians' Desk Reference, 48 Edition, pp. 1112-1113 (Dec. 1994), "Dipentum"
Physicians' Desk Reference, 48 Edition, pp. 1805-1806 (Dec. 1994), "Asacol"
Physicians' Desk Reference, 48 Edition, pp. 2307-2309 (Dec. 1994), "Rowasa"
January 6, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
